New drug could boost growth in kids with dwarfism
NCT ID NCT06842355
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 28 times
Summary
This study tests a new medicine called TYRA-300 in children aged 3 to 10 with achondroplasia (the most common form of dwarfism). The goal is to see if it is safe and can help them grow taller. About 92 children will take part, and the study will look at growth speed and side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACHONDROPLASIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Children's Hospital Colorado
RECRUITINGAurora, Colorado, 80045, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Children's Medical Center, Dallas
RECRUITINGDallas, Texas, 75235, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Johns Hopkins University School of Medicine
RECRUITINGBaltimore, Maryland, 21205, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Lundquist Institute for Biomedical Innovation
RECRUITINGTorrance, California, 90502, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Nemours Alfred I duPont Hospital for Children
RECRUITINGWilmington, Delaware, 19803, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Royal Children's Hospital
RECRUITINGParkville, Victoria, 3052, Australia
Contact Email: •••••@•••••
-
The Children's Hospital at Westmead
RECRUITINGWestmead, New South Wales, 2145, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Hospital for Sick Children
RECRUITINGToronto, Ontario, M5G1X8, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Uncommon Cures
RECRUITINGChevy Chase, Maryland, 20815, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Unidad de Cirugía Artroscópica (MIKS Hospital)
RECRUITINGVitoria-Gasteiz, Alava, 1008, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Missouri
RECRUITINGColumbia, Missouri, 65201, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Texas Health Science Center Medical School at Houston
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Wisconsin-Madison
RECRUITINGMadison, Wisconsin, 53715, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Vanderbilt University Medical Center
RECRUITINGNashville, Tennessee, 37232, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Washington University
RECRUITINGSt Louis, Missouri, 63130, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.